26-A-15083-ACC SGLT2 INHIBITORS AND RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH LEFT ATRIAL ENLARGEMENT: INSIGHTS FROM A LARGE REAL-WORLD COHORT
JACC · 2026-04 · 87 (13) · A126
DOI: 10.1016/j.jacc.2026.02.319 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Mohammad Alazzeh und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alazzeh, M., Chaudhry, A., Ahmed, H., Odat, M., Othman, D., Razzak, I. A., darwish, M., Basrak, M. T., & Inanc, I. H. (2026). 26-A-15083-ACC SGLT2 INHIBITORS AND RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH LEFT ATRIAL ENLARGEMENT: INSIGHTS FROM A LARGE REAL-WORLD COHORT. JACC, 87(13), A126. https://doi.org/10.1016/j.jacc.2026.02.319
Vancouver
Alazzeh M, Chaudhry A, Ahmed H, Odat M, Othman D, Razzak IA, et al. 26-A-15083-ACC SGLT2 INHIBITORS AND RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH LEFT ATRIAL ENLARGEMENT: INSIGHTS FROM A LARGE REAL-WORLD COHORT. JACC. 2026;87(13):A126. doi:10.1016/j.jacc.2026.02.319
BibTeX
@article{Alazzeh2026,
author = {Alazzeh, Mohammad and Chaudhry, Afnan and Ahmed, Hatem and Odat, Motaz and Othman, Dalia and Razzak, Imad Alabdul and darwish, Mohamed and Basrak, Mohamad Talal and Inanc, Ibrahim Halil},
title = {26-A-15083-ACC SGLT2 INHIBITORS AND RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH LEFT ATRIAL ENLARGEMENT: INSIGHTS FROM A LARGE REAL-WORLD COHORT},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A126},
doi = {10.1016/j.jacc.2026.02.319}
}
EUVIMED